1Karkkainen MJ, Makinen T,Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nature Cell Biol,2002, 4: E2-E5.
2Saharinen P, Petrova TV. Molecular Regulation of Lymphangiogenesis. Ann NY Acad Sci,2004, 1014:76-87.
3Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res,2002, 62:7059-7065.
4Kriehuber E, Breiteneder SG, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med, 2001, 194:797-808.
5Carreira CM, Nasser SM, Tomaso E, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res,2001, 61: 8079-8084.
6Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBOJ,2002, 21:1505-1513.
7Munoz-Guerra MF, Marazuela EG, Martin-Villar E, et al. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer, 2004, 100:553-560.
8Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science,1997, 276:1423-1425.
9Shimizu K, Kubo H, Yamaguchi K,et al. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci,2004, 95:328-333.
10Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med, 2001, 7:199-205.
二级参考文献15
1Ohno M, Nakamura T, Kunimoto Y, et al. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. Oncol Rep, 2003, 10: 939-943.
2Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol, 1993, 10: 302-313.
3Wulff C, Dickson SE, Duncan WC, et al. Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod, 2001, 16: 2515-2524.
4Yoon YS, Murayama T, Gravereaux E, et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest, 2003, 111: 717-725.
5Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res, 2001, 21 (4A) :2351-2355.
6Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res, 2001, 7:462-468.
7Clarijs R, Ruiter DJ, de Waal RM. Lymphangiogenesis in malignant tumours: does it occur? J Pathol, 2001, 193: 143-146.
8Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med, 2001, 7: 192-198.
9Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 2002, 62 : 1315-1320.
10Shimizu K, Kubo H, Yamaguchi K, et al. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci, 2004, 95:328-333.
